These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 15340128)
21. Iclaprim, a novel diaminopyrimidine for the treatment of resistant gram-positive infections. Sincak CA; Schmidt JM Ann Pharmacother; 2009 Jun; 43(6):1107-14. PubMed ID: 19435963 [TBL] [Abstract][Full Text] [Related]
22. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246 [TBL] [Abstract][Full Text] [Related]
23. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium. Allen GP; Bierman BC Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921 [TBL] [Abstract][Full Text] [Related]
30. Antimicrobial resistance: factors and outcomes. Fish DN; Ohlinger MJ Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001 [TBL] [Abstract][Full Text] [Related]
31. Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration. Rodríguez JC; Cebrián L; López M; Ruiz M; Royo G Int J Antimicrob Agents; 2005 Mar; 25(3):221-5. PubMed ID: 15737516 [TBL] [Abstract][Full Text] [Related]
32. Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin. Ferran A; Dupouy V; Toutain PL; Bousquet-Mélou A Antimicrob Agents Chemother; 2007 Nov; 51(11):4163-6. PubMed ID: 17709467 [TBL] [Abstract][Full Text] [Related]
33. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
34. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa. Pasquali F; Manfreda G Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619 [TBL] [Abstract][Full Text] [Related]
35. Antibiotic resistance in common pathogens reinforces the need to minimise surgical site infections. Dohmen PM J Hosp Infect; 2008 Nov; 70 Suppl 2():15-20. PubMed ID: 19022117 [TBL] [Abstract][Full Text] [Related]
36. The tide of antimicrobial resistance and selection. Wilcox MH Int J Antimicrob Agents; 2009 Aug; 34 Suppl 3():S6-10. PubMed ID: 19596111 [TBL] [Abstract][Full Text] [Related]
37. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis. Briscoe D; Rubowitz A; Assia E Orbit; 2005 Mar; 24(1):29-32. PubMed ID: 15764113 [TBL] [Abstract][Full Text] [Related]